CSG452
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CSG452, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis [Phase 2]